Scientific Data · 2020 · 33 citations · 52 references
Life SciencesBiochemistryImmunologyProtein BiochemistryProteomicsProteomics InformaticsDe Novo Peptide SequencingPeptide AnalysisPeptide IdentificationProtein Database SearchProtein Sequence AnalysisProteolytic ProcessingDruggable Target DiscoveryPeptide Database SearchProtease-catalyzed Peptide CleavageProteasome SystemProteomics-based Antigen Discovery
T cells. They can cut proteins and release their fragments or recombine non-contiguous fragments thereby generating novel sequences, i.e. spliced peptides. Understanding which are the driving forces and the sequence preferences of both reactions can streamline target discovery in immunotherapies against cancer, infection and autoimmunity. Here, we present a large database of spliced and non-spliced peptides generated by proteasomes in vitro, which is available as simple CSV file and as a MySQL database. To generate the database, we performed in vitro digestions of 55 unique synthetic polypeptide substrates with different proteasome isoforms and experimental conditions. We measured the samples using three mass spectrometers, filtered and validated putative peptides, identified 22,333 peptide product sequences (15,028 spliced and 7,305 non-spliced product sequences). Our database and datasets have been deposited to the Mendeley (doi:10.17632/nr7cs764rc.1) and PRIDE (PXD016782) repositories. We anticipate that this unique database can be a valuable source for predictors of proteasome-catalyzed peptide hydrolysis and splicing, with various future translational applications.
52
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder et al. · Science · 2015 · 7.9K citations
Medicine, Immunology, Oncology +17
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin, Xiuli Zhang, Heiko Schuster et al. · Nature · 2014 · 2K citations · Full text
Life Sciences, Immunology, Oncology +10
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
Eric Tran, Paul F. Robbins, Yong‐Chen Lu et al. · New England Journal of Medicine · 2016 · 1.4K citations · Full text
Life Sciences, Immunology, Oncology +16
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Vinod P. Balachandran, Marta Łuksza, Julia N. Zhao et al. · Nature · 2017 · 1.2K citations · Full text
Medicine, Cancer Biology, Oncology +11
A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
Marta Łuksza, Nadeem Riaz, Vladimir Makarov et al. · Nature · 2017 · 666 citations · Full text